​

BioLineRx Ownership | Who Owns BioLineRx?


OverviewForecastChartTranscripts

BioLineRx Ownership Summary


BioLineRx is owned by 12.78% institutional investors, 3.43% insiders, and 83.79% retail investors. Cvi is the largest institutional shareholder, holding 1.13% of BLRX shares. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.04% of its assets in BioLineRx shares.

BLRX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockBioLineRx12.78%3.43%83.79%
SectorHealthcare Stocks 129.40%12.08%-41.48%
IndustryBiotech Stocks 181.71%11.69%-93.40%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Cvi815.68K1.13%$461.68K
Stifel financial20.04K0.45%$47.10K
Renaissance18.90K0.43%$44.41K
Pvg asset management123.58K0.17%$70.43K
Rhumbline advisers2.48K0.06%$5.82K
Wells fargo & company/mn1.75K0.04%$4.03K
Citadel advisors11.20K0.02%$6.34K
Susquehanna group, llp87.22K0.01%$18.53K
Nemes rush group250.000.01%$588.00
Ubs group157.000.00%$369.00

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Cvi815.68K0.40%$461.68K
Pvg asset management123.58K0.28%$70.43K
Renaissance18.90K0.00%$44.41K
Rockefeller capital management---
Baader bank aktiengesellschaft---
Susquehanna group, llp87.22K-$18.53K
Orin green financial---
Watts gwilliam---
Advisor group51.00-$119.00
Two sigma securities---

Top Buyers

HolderShares% AssetsChange
Cvi815.68K0.40%815.68K
Pvg asset management123.58K0.28%123.58K
Susquehanna group, llp87.22K-69.18K
Royal bank of canada20.20K-20.20K
Stifel financial20.04K-20.04K

Top Sellers

HolderShares% AssetsChange
Highbridge capital management---1.01M
Alyeska investment group---866.50K
Envestnet asset management---239.19K
Values first advisors---166.45K
Atria investments---133.97K

New Positions

HolderShares% AssetsChangeValue
Cvi815.68K0.40%815.68K$461.68K
Pvg asset management123.58K0.28%123.58K$70.43K
Royal bank of canada20.20K-20.20K$4.00K
Stifel financial20.04K-20.04K$47.10K
Caitong asset management2.00-2.00$5.00

Sold Out

HolderChange
Jpmorgan chase-1.00
Citigroup-1.00
Banque cantonale vaudoise-1.00
Rockefeller capital management-12.00
Morgan stanley-100.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202616-567,560752.22%12568.34%912.50%1-75.00%
Jun 30, 20261515.38%66,570239.68%1767.17%7133.33%433.33%
Mar 31, 202612-20.00%19,491-59.18%-35.13%3-50.00%350.00%
Dec 31, 2025157.14%47,75073.04%1238.06%620.00%2-
Sep 30, 202514-26.32%27,595-58.33%-24.85%5-50.00%2-33.33%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Nasdaq Composite Index999.000.04%-

Insider Transactions Trends


DateBuySell
2026 Q4--
2026 Q1--
2025 Q1--
2024 Q4--
2024 Q1--

BLRX Ownership FAQ


Who Owns BioLineRx?

BioLineRx shareholders are primarily institutional investors at 12.78%, followed by 3.43% insiders and 83.79% retail investors. The average institutional ownership in BioLineRx's industry, Biotech Stocks , is 181.71%, which BioLineRx falls below.

Who owns the most shares of BioLineRx?

BioLineRx’s largest shareholders are Cvi (815.68K shares, 1.13%), Stifel financial (20.04K shares, 0.45%), and Renaissance (18.9K shares, 0.43%). Together, they hold 2.00% of BioLineRx’s total shares outstanding.

Does Blackrock own BioLineRx?

BlackRock is not among the top 10 institutional shareholders of BioLineRx.

Who is BioLineRx’s biggest shareholder by percentage of total assets invested?

Cvi is BioLineRx’s biggest shareholder by percentage of total assets invested, with 0.40% of its assets in 815.68K BioLineRx shares, valued at 461.68K$.

Who is the top mutual fund holder of BioLineRx shares?

Fidelity Nasdaq Composite Index is the top mutual fund holder of BioLineRx shares, with 0.04% of its total shares outstanding invested in 999 BioLineRx shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools